287 related articles for article (PubMed ID: 34966712)
41. Cost Effectiveness of Support for People Starting a New Medication for a Long-Term Condition Through Community Pharmacies: An Economic Evaluation of the New Medicine Service (NMS) Compared with Normal Practice.
Elliott RA; Tanajewski L; Gkountouras G; Avery AJ; Barber N; Mehta R; Boyd MJ; Latif A; Chuter A; Waring J
Pharmacoeconomics; 2017 Dec; 35(12):1237-1255. PubMed ID: 28776320
[TBL] [Abstract][Full Text] [Related]
42. Cost-effectiveness analysis of acupuncture compared with usual care for acute non-specific low back pain: secondary analysis of a randomised controlled trial.
Skonnord T; Fetveit A; Skjeie H; Brekke M; Grotle M; Klovning A; Aas E
Acupunct Med; 2022 Apr; 40(2):123-132. PubMed ID: 34847780
[TBL] [Abstract][Full Text] [Related]
43. Cost-effectiveness analysis of proton beam therapy for treatment decision making in paranasal sinus and nasal cavity cancers in China.
Li G; Qiu B; Huang YX; Doyen J; Bondiau PY; Benezery K; Xia YF; Qian CN
BMC Cancer; 2020 Jun; 20(1):599. PubMed ID: 32590957
[TBL] [Abstract][Full Text] [Related]
44. Cost-effectiveness analysis of a community-based colorectal cancer screening program in Shanghai, China.
Li XP; Chen HM; Lei XH; Dou GS; Chen YC; Chen LP; Zhang Y; Zhao GM; Zhong W
J Dig Dis; 2021 Aug; 22(8):452-462. PubMed ID: 34086400
[TBL] [Abstract][Full Text] [Related]
45. Potential lifetime cost-effectiveness of catheter-based renal sympathetic denervation in patients with resistant hypertension.
Dorenkamp M; Bonaventura K; Leber AW; Boldt J; Sohns C; Boldt LH; Haverkamp W; Frei U; Roser M
Eur Heart J; 2013 Feb; 34(6):451-61. PubMed ID: 23091202
[TBL] [Abstract][Full Text] [Related]
46. Cost-Effectiveness Analysis of a Once-Daily Single-Inhaler Triple Therapy for Patients with Chronic Obstructive Pulmonary Disease (COPD) Using the FULFIL Trial: A Spanish Perspective.
Schroeder M; Benjamin N; Atienza L; Biswas C; Martin A; Whalen JD; Izquierdo Alonso JL; Riesco Miranda JA; Soler-Cataluña JJ; Huerta A; Ismaila AS
Int J Chron Obstruct Pulmon Dis; 2020; 15():1621-1632. PubMed ID: 32764908
[TBL] [Abstract][Full Text] [Related]
47. Population impact and cost-effectiveness of artificial intelligence-based diabetic retinopathy screening in people living with diabetes in Australia: a cost effectiveness analysis.
Hu W; Joseph S; Li R; Woods E; Sun J; Shen M; Jan CL; Zhu Z; He M; Zhang L
EClinicalMedicine; 2024 Jan; 67():102387. PubMed ID: 38314061
[TBL] [Abstract][Full Text] [Related]
48. Cost-effectiveness of an integrated 'fast track' rehabilitation service for multi-trauma patients: A non-randomized clinical trial in the Netherlands.
Wijnen BFM; Hemmen B; Bouman AIE; van de Meent H; Ambergen T; Brink PRG; Seelen HAM; Evers SMAA
PLoS One; 2019; 14(3):e0213980. PubMed ID: 30901353
[TBL] [Abstract][Full Text] [Related]
49. Comparative cost-effectiveness of amisulpride and olanzapine in the treatment of schizophrenia in China.
Yi ZM; Men P; Qu S; Li C; Yu X; Zhai S
Expert Rev Pharmacoecon Outcomes Res; 2020 Jun; 20(3):313-320. PubMed ID: 32293194
[TBL] [Abstract][Full Text] [Related]
50. Cost-effectiveness and Net Monetary Benefit of Durvalumab Consolidation Therapy Versus No Consolidation Therapy After Chemoradiotherapy in Stage III Non-small Cell Lung Cancer in the Italian National Health Service.
Armeni P; Borsoi L; Fornaro G; Jommi C; Grossi F; Costa F
Clin Ther; 2020 May; 42(5):830-847. PubMed ID: 32354495
[TBL] [Abstract][Full Text] [Related]
51. Corneal Collagen Cross-Linking in the Management of Keratoconus in Canada: A Cost-Effectiveness Analysis.
Leung VC; Pechlivanoglou P; Chew HF; Hatch W
Ophthalmology; 2017 Aug; 124(8):1108-1119. PubMed ID: 28457614
[TBL] [Abstract][Full Text] [Related]
52. Cost-effectiveness of adding novel or group 5 interventions to a background regimen for the treatment of multidrug-resistant tuberculosis in Germany.
Wirth D; Dass R; Hettle R
BMC Health Serv Res; 2017 Mar; 17(1):182. PubMed ID: 28270207
[TBL] [Abstract][Full Text] [Related]
53. Cost-Effectiveness of Group-Based Outpatient Physical Therapy After Total Knee Replacement: Results From the Economic Evaluation Alongside the ARENA Multicenter Randomized Controlled Trial.
Barbosa EC; Wylde V; Thorn J; Sanderson E; Lenguerrand E; Artz N; Blom AW; Marques EMR
Arthritis Care Res (Hoboken); 2022 Dec; 74(12):1970-1977. PubMed ID: 35468266
[TBL] [Abstract][Full Text] [Related]
54. Cost-effectiveness of Corticosteroid Nasal Spray vs Surgical Therapy in Patients With Severe to Extreme Anatomical Nasal Obstruction.
Teti VP; Akdagli S; Most SP
JAMA Facial Plast Surg; 2016 May; 18(3):165-70. PubMed ID: 26747790
[TBL] [Abstract][Full Text] [Related]
55. Telemonitoring Versus Usual Care for Elderly Patients With Heart Failure Discharged From the Hospital in the United States: Cost-Effectiveness Analysis.
Jiang X; Yao J; You JH
JMIR Mhealth Uhealth; 2020 Jul; 8(7):e17846. PubMed ID: 32407288
[TBL] [Abstract][Full Text] [Related]
56. A cost-effectiveness analysis of capecitabine maintenance therapy versus routine follow-up for early-stage triple-negative breast cancer patients after standard treatment from a perspective of Chinese society.
Li JB; Lin ZC; Wong MCS; Wang HHX; Li M; Li S
BMC Med; 2022 Sep; 20(1):320. PubMed ID: 36156186
[TBL] [Abstract][Full Text] [Related]
57. Cost-Effectiveness of Total Knee Arthroplasty vs Nonoperative Management in Normal, Overweight, Obese, Severely Obese, Morbidly Obese, and Super-Obese Patients: A Markov Model.
Ponnusamy KE; Vasarhelyi EM; Somerville L; McCalden RW; Marsh JD
J Arthroplasty; 2018 Jul; 33(7S):S32-S38. PubMed ID: 29550168
[TBL] [Abstract][Full Text] [Related]
58. Analyzing cost-effectiveness of ulnar and median nerve transfers to regain forearm flexion.
Wali AR; Park CC; Brown JM; Mandeville R
Neurosurg Focus; 2017 Mar; 42(3):E11. PubMed ID: 28245686
[TBL] [Abstract][Full Text] [Related]
59. Cost-utility analysis of empagliflozin in heart failure patients with reduced and preserved ejection fraction in China.
Tang Y; Sang H
Front Pharmacol; 2022; 13():1030642. PubMed ID: 36386229
[No Abstract] [Full Text] [Related]
60. Economic evaluation and budget impact analysis of the surveillance program for hepatocellular carcinoma in Thai chronic hepatitis B patients.
Sangmala P; Chaikledkaew U; Tanwandee T; Pongchareonsuk P
Asian Pac J Cancer Prev; 2014; 15(20):8993-9004. PubMed ID: 25374242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
